Breaking News Instant updates and real-time market news.

2021-03-02 08:55:03 AAPL Apple $127.79 / +6.54 (+5.39%) , AMC AMC Entertainment $9.20 / +1.19 (+14.86%) … 08:55 03/02/21 03/02 08:55 03/02/21 08:55	Notable open interest changes for March 2nd Monday's total option volume of 37.6 million contracts resulted in net open interest growth of 6.23 million calls and 3.78 million puts. Apple (AAPL), AMC Entertainment (AMC), NIO (NIO) and Palantir Technologies (PLTR) saw the greatest growth. Top five new positions opened include 40k Farfetch Limited (FTCH) Mar-21 50 puts, 38k L Brands (LB) Mar-21 65 calls, 25k Enterprise Products (EPD) Apr-21 20 puts, 24k AMC Entertainment (AMC) 3/5 weekly 9 calls and 21k Snap Inc. (SNAP) 3/5 weekly 60 puts. AAPL Apple $127.79 / +6.54 (+5.39%) AMC AMC Entertainment $9.20 / +1.19 (+14.86%) NIO NIO $49.79 / +3.08 (+6.59%) PLTR Palantir $24.84 / +0.96 (+4.02%)	10 Mar 17 Mar 11 Jun 31 Aug 14 Dec
AAPL AMC NIO PLTR AAPL Apple $127.79 / +6.54 (+5.39%) 03/01/21 Wedbush Asia checks bullish for Apple iPhone 12 builds, says Wedbush 03/01/21 JPMorgan Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan 02/25/21 JPMorgan JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts 02/24/21 Piper Sandler Piper sees Apple developing 'full-blown' branded electric vehicle AMC AMC Entertainment $9.20 / +1.19 (+14.86%) 02/04/21 Citi Citi sees 'dramatically reduced' bankruptcy risk for AMC Entertainment 02/01/21 MKM Partners AMC Entertainment downgraded to Sell from Neutral at MKM Partners 02/01/21 MKM Partners AMC Entertainment downgraded to Sell from Neutral at MKM Partners 01/26/21 Loop Capital AMC Entertainment's capital raise results in massive dilution, says Loop Capital NIO NIO $49.79 / +3.08 (+6.59%) 02/26/21 HSBC NIO price target raised to $54 from $44.70 at HSBC 02/09/21 Deutsche Bank NIO job post shows ambitions to enter U.S. market, says Deutsche Bank 01/28/21 Morgan Stanley NIO price target raised to $80 from $33 at Morgan Stanley 01/22/21 Fly Intel: Top five analyst initiations PLTR Palantir $24.84 / +0.96 (+4.02%) 02/17/21 Fly Intel: Top five analyst upgrades 02/17/21 RBC Capital Palantir price target raised to $27 from $15 at RBC Capital 02/17/21 Jefferies Palantir 'a highly unique story for long-term investors,' says Jefferies 02/17/21 Morgan Stanley Palantir price target raised to $19 from $17 at Morgan Stanley

2021-03-02 08:55:03

AAPL

Apple

$127.79 / +6.54 (+5.39%)

, AMC

AMC Entertainment

$9.20 / +1.19 (+14.86%)

… 08:55

03/02/21

03/02

08:55

03/02/21

08:55

Notable open interest changes for March 2nd

Monday's total option volume of 37.6 million contracts resulted in net open interest growth of 6.23 million calls and 3.78 million puts. Apple (AAPL), AMC Entertainment (AMC), NIO (NIO) and Palantir Technologies (PLTR) saw the greatest growth. Top five new positions opened include 40k Farfetch Limited (FTCH) Mar-21 50 puts, 38k L Brands (LB) Mar-21 65 calls, 25k Enterprise Products (EPD) Apr-21 20 puts, 24k AMC Entertainment (AMC) 3/5 weekly 9 calls and 21k Snap Inc. (SNAP) 3/5 weekly 60 puts.

AAPL

Apple

$127.79 / +6.54 (+5.39%)

AMC

AMC Entertainment

$9.20 / +1.19 (+14.86%)

NIO

$49.79 / +3.08 (+6.59%)

PLTR

Palantir

$24.84 / +0.96 (+4.02%)

10
Mar
17
Mar

11
Jun
31
Aug
14
Dec

AAPL
AMC
NIO
PLTR

AAPL Apple

$127.79 / +6.54 (+5.39%)

03/01/21 Wedbush: Asia checks bullish for Apple iPhone 12 builds, says Wedbush

03/01/21 JPMorgan: Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan

02/25/21 JPMorgan: JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts

02/24/21 Piper Sandler: Piper sees Apple developing 'full-blown' branded electric vehicle

AMC AMC Entertainment

$9.20 / +1.19 (+14.86%)

02/04/21 Citi: Citi sees 'dramatically reduced' bankruptcy risk for AMC Entertainment

02/01/21 MKM Partners: AMC Entertainment downgraded to Sell from Neutral at MKM Partners

02/01/21 MKM Partners: AMC Entertainment downgraded to Sell from Neutral at MKM Partners

01/26/21 Loop Capital: AMC Entertainment's capital raise results in massive dilution, says Loop Capital

NIO NIO

$49.79 / +3.08 (+6.59%)

02/26/21 HSBC: NIO price target raised to $54 from $44.70 at HSBC

02/09/21 Deutsche Bank: NIO job post shows ambitions to enter U.S. market, says Deutsche Bank

01/28/21 Morgan Stanley: NIO price target raised to $80 from $33 at Morgan Stanley

01/22/21: Fly Intel: Top five analyst initiations

PLTR Palantir

$24.84 / +0.96 (+4.02%)

02/17/21: Fly Intel: Top five analyst upgrades

02/17/21 RBC Capital: Palantir price target raised to $27 from $15 at RBC Capital

02/17/21 Jefferies: Palantir 'a highly unique story for long-term investors,' says Jefferies

02/17/21 Morgan Stanley: Palantir price target raised to $19 from $17 at Morgan Stanley

TODAY'S FREE FLY STORIES

Recommendations	HCA Healthcare price target raised to $232 from $205 at Mizuho » 06:50 04/23/21 04/23 06:50 04/23/21 06:50 HCA HCA Healthcare $201.52 / +3.96 (+2.00%) Mizuho analyst Ann Hynes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 02/24/21 Brookdale Senior Living to sell 80% stake in BHS to HCA Healthcare for $400M 01/26/21 HCA Healthcare uses Its COVID-19 registry to aid research in area 01/21/21 HCA Healthcare in new JV with A Plus International to expand PPE access 10/26/20 HCA Healthcare sees FY21 EBITDA $10.25B-$10.65B HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 06:45 Today RBC Capital HCA Healthcare price target raised to $232 from $205 at RBC Capital 04/14/21 Truist HCA Healthcare price target raised to $230 from $200 at Truist 04/13/21 Deutsche Bank HCA Healthcare price target raised to $210 from $180 at Deutsche Bank 04/09/21 Mizuho HCA Healthcare price target raised to $205 from $195 at Mizuho HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 04/22/21 HCA Healthcare raises FY21 EPS view to $13.30-$14.30 from $12.10-$13.10 04/22/21 HCA Healthcare reports Q1 EPS $4.14, consensus $3.32 04/21/21 Notable companies reporting before tomorrow's open 04/21/21 Notable companies reporting before tomorrow's open HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says HCA HCA Healthcare $201.52 / +3.96 (+2.00%) 04/22/21 Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Pre-market Movers 11/14/20 Week in review: How Trump's policies moved stocks 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 HCA Healthcare, Inc.
Recommendations	Danaher price target raised to $280 from $260 at Wells Fargo » 06:49 04/23/21 04/23 06:49 04/23/21 06:49 DHR Danaher / + Wells Fargo analyst Dan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events Options DHR Danaher / + 03/23/21 Beckman Coulter receives Emergency Use Authorization for antibody test 03/11/21 Danaher not seeing decline in Covid testing business 03/02/21 Director of Danaher Mitchell Rales purchases $1.4M in shares 01/13/21 Danaher expects Q4 revenue up approx. 38.5% y-o-y, consensus $6.44B DHR Danaher / + 06:42 Today KeyBanc Danaher price target raised to $315 from $280 at KeyBanc 06:41 Today RBC Capital Danaher price target raised to $285 from $253 at RBC Capital 06:32 Today Citi Danaher price target raised to $315 from $275 at Citi 04/08/21 Citi Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat DHR Danaher / + 04/22/21 Danaher sees 2021 non-GAAP core revenue growth in high-teens percent range 04/22/21 Danaher sees Q2 non-GAAP core revenue growth in mid-20 percent range 04/22/21 Danaher reports Q1 adjusted EPS $2.52, consensus $1.75 04/21/21 Notable companies reporting before tomorrow's open 08 May DHR Danaher / + 03/26/21 Danaher, Fortive interested in joint bid for Renishaw, Bloomberg reports 03/26/21 Danaher said to mull joint bid with Fortive for Renishaw, Bloomberg says 05/05/21 Danaher Corporation DHR Danaher / + 04/13/21 Early notable gainers among liquid option names on April 13th 01/22/21 Early notable gainers among liquid option names on January 22nd
Upgrade	Cimarex Energy upgraded to Strong Buy from Outperform at Raymond James » 06:49 04/23/21 04/23 06:49 04/23/21 06:49 XEC Cimarex Energy $60.88 / +0.01 (+0.02%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options XEC Cimarex Energy $60.88 / +0.01 (+0.02%) 04/15/21 U.S. Well Services files patent suit against Halliburton and Cimarex Energy 01/14/21 Halliburton announces 'first successful' grid-powered fracturing operation 11/04/20 Cimarex Energy sees 2020 average daily production volume 250-255 MBOE per day 11/04/20 Cimarex Energy sees 2020 average daily production volume 250-255 MBOE per day XEC Cimarex Energy $60.88 / +0.01 (+0.02%) 04/22/21 MKM Partners Cimarex Energy upgraded to Buy from Neutral at MKM Partners 04/20/21 Mizuho Cimarex Energy price target raised to $90 from $76 at Mizuho 04/15/21 Scotiabank Cimarex Energy upgraded to Outperform amid sector rating shake-up at Scotiabank 04/15/21 Scotiabank Cimarex Energy upgraded to Outperform from Sector Perform at Scotiabank XEC Cimarex Energy $60.88 / +0.01 (+0.02%) 02/22/21 Cimarex Energy reports Q4 EPS 89c, consensus 68c 11/04/20 Cimarex Energy reports Q3 adjusted EPS 51c, consensus 26c 05/06/21 Cimarex Energy - XEC 05/12/21 Cimarex Energy Co. XEC Cimarex Energy $60.88 / +0.01 (+0.02%) 01/04/21 Early notable gainers among liquid option names on January 4th
Upgrade	Continental Resources upgraded to Outperform from Market Perform at Raymond James » 06:49 04/23/21 04/23 06:49 04/23/21 06:49 CLR Continental Resources / + Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CLR Continental Resources / + 04/13/21 Continental Resources reports preliminary Q1 oil production 152 MBopd 03/22/21 Continental Resources announces redemption of balance of 5% senior notes 02/16/21 Continental Resources sees FY21 CapEx $1.4B CLR Continental Resources / + 04/20/21 Mizuho Continental Resources price target raised to $29 from $28 at Mizuho 03/24/21 MKM Partners Continental Resources upgraded to Buy at MKM Partners on valuation 03/24/21 MKM Partners Continental Resources upgraded to Buy from Neutral at MKM Partners 03/23/21 Goldman Sachs Continental Resources assumed with a Sell at Goldman Sachs CLR Continental Resources / + 02/16/21 Continental Resources reports Q4 adjusted EPS (23c), consensus (8c) 11/05/20 Continental Resources reports Q3 adjusted EPS (16c), consensus (23c) CLR Continental Resources / + 03/29/21 Fly Insider: Babcock & Wilcox, Bill.com among weeks notable insider trades 02/16/21 Fly Intel: After-Hours Movers 04/29/21 Continental Resources - CLR 05/20/21 Continental Resources Inc.
Downgrade	Range Resources downgraded to Underperform from Market Perform at Raymond James » 06:48 04/23/21 04/23 06:48 04/23/21 06:48 RRC Range Resources / + Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options RRC Range Resources / + 02/23/21 Range Resources sees 2021 all-in capital budget $425M 01/12/21 Range Resources rises 15.9% 01/11/21 U.S. Well Services, Range Resources extend electric frac contract 10/30/20 Range Resources falls -16.1% RRC Range Resources / + 04/20/21 Mizuho Range Resources price target lowered to $11 from $13 at Mizuho 03/23/21 Goldman Sachs Range Resources assumed with a Sell at Goldman Sachs 03/23/21 Citi Range Resources price target raised to $10.50 from $7.50 at Citi 03/15/21 Piper Sandler Range Resources price target raised to $9 from $8 at Piper Sandler RRC Range Resources / + 02/23/21 Range Resources reports Q4 adjusted EPS 2c, consensus 6c 10/29/20 Range Resources reports Q3 adjusted EPS (5c), consensus (2c) RRC Range Resources / + 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 10/29/20 Fly Intel: After-Hours Movers 04/27/21 Range Resources - RRC 05/12/21 Range Resources Corp. RRC Range Resources / + 01/15/21 Early notable gainers among liquid option names on January 15th 01/12/21 Early notable gainers among liquid option names on January 12th 01/05/21 Early notable gainers among liquid option names on January 5th 12/10/20 Early notable gainers among liquid option names on December 10th

Downgrade	Southwestern Energy downgraded to Underperform from Market Perform at Raymond James » 06:48 04/23/21 04/23 06:48 04/23/21 06:48 SWN Southwestern Energy $4.02 / +0.075 (+1.90%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options SWN Southwestern Energy $4.02 / +0.075 (+1.90%) 04/08/21 Southwestern Energy falls -8.6% 01/04/21 Southwestern Energy announces passing of CFO Julian Bott 12/23/20 Southwestern Energy rises 9.8% SWN Southwestern Energy $4.02 / +0.075 (+1.90%) 04/20/21 Mizuho Southwestern Energy price target raised to $5 from $4 at Mizuho 03/23/21 Goldman Sachs Southwestern Energy assumed with a Buy at Goldman Sachs 03/23/21 Citi Southwestern Energy price target raised to $4.75 from $3.50 at Citi 03/08/21 Johnson Rice Southwestern Energy upgraded to Buy from Hold at Johnson Rice SWN Southwestern Energy $4.02 / +0.075 (+1.90%) 02/25/21 Southwestern Energy reports Q4 EPS 18c, consensus 14c 10/29/20 Southwestern Energy reports Q3 adjusted EPS 8c, consensus 2c 14 Aug 06/22/21 2021 Energy, Power & Renewables Virtual Conference 04/30/21 Southwestern Energy - SWN 05/18/21 Southwestern Energy Co. SWN Southwestern Energy $4.02 / +0.075 (+1.90%) 12/28/20 Unusually active option classes on open December 28th 12/23/20 Unusually active option classes on open December 23rd 12/03/20 Unusually active option classes on open December 3rd
Hot Stocks	Cathie Wood's ARK Investment discloses another 1.2M shares of Skillz bought » 06:48 04/23/21 04/23 06:48 04/23/21 06:48 SKLZ Skillz $16.62 / -0.13 (-0.78%) Shares of Skillz are up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SKLZ Skillz $16.62 / -0.13 (-0.78%) 04/22/21 Skillz rises 14.6% 04/22/21 Skillz up over 9.5% at $18.37 in pre-market after ARK Investment buys 04/21/21 Cathie Wood's ARK Investment discloses 5.07M shares of Skillz bought today 04/21/21 Skillz rises 20.1% SKLZ Skillz $16.62 / -0.13 (-0.78%) 04/22/21 Jefferies Skillz initiated with a Hold at Jefferies 03/25/21 Stifel Skillz price target lowered to $28 from $30 at Stifel 03/11/21 Canaccord Skillz price target raised to $33 from $32 at Canaccord 02/25/21 Fly Intel: Top five analyst initiations SKLZ Skillz $16.62 / -0.13 (-0.78%) 03/25/21 Skillz sees Q1 revenue $80M, consensus $76.44M 03/10/21 Skillz sees 2021 revenue $366M, consensus $366.09M. 03/10/21 Skillz reports Q4 EPS (14c), consensus (10c) 19 Mar SKLZ Skillz $16.62 / -0.13 (-0.78%) 04/21/21 Skillz volatile after another bearish report emerges, Casino.org reports 03/15/21 Skillz 'simply another skill-based gambling startup,' short report says 03/08/21 Wolfpack says shorting Skillz, sees revenue projections as 'farcical' SKLZ Skillz $16.62 / -0.13 (-0.78%) 04/22/21 Fly Intel: Pre-market Movers 03/19/21 Fly Intel: Wall Street's top stories for Friday 03/19/21 Fly Intel: Wall Street's top stories at midday 03/19/21 Fly Intel: Pre-market Movers 05/04/21 Skillz - SKLZ 05/26/21 Skillz Inc SKLZ Skillz $16.62 / -0.13 (-0.78%) 04/22/21 Unusually active option classes on open April 22nd 04/21/21 Skillz call volume above normal and directionally bullish 03/15/21 Skillz call volume above normal and directionally bullish 03/15/21 Unusually active option classes on open March 15th
Recommendations	TAL Education price target lowered to $75 from $84 at Morgan Stanley » 06:48 04/23/21 04/23 06:48 04/23/21 06:48 TAL TAL Education $61.63 / -1.42 (-2.25%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TAL TAL Education $61.63 / -1.42 (-2.25%) 03/30/21 TAL Education rises 7.9% 03/26/21 TAL Education falls -18.4% 03/26/21 TAL Education falls -8.7% 01/21/21 TAL Education rises 13.8% TAL TAL Education $61.63 / -1.42 (-2.25%) 04/15/21 CLSA TAL Education transferred with an Outperform at CLSA 03/23/21 Citi Citi downgrades TAL Education to Neutral, opens 'negative Catalyst Watch' 03/23/21 Citi TAL Education downgraded to Neutral from Buy at Citi 01/28/21 Goldman Sachs TAL Education downgraded to Neutral from Buy at Goldman Sachs TAL TAL Education $61.63 / -1.42 (-2.25%) 04/22/21 TAL Education sees Q1 revenue $1.3B-$1.32B, consensus $1.3B 04/22/21 TAL Education reports Q4 adjusted EPS (14), consensus (15c) 01/21/21 TAL Education sees Q4 revenue $1.18B-$1.2B, consensus $1.17B 01/21/21 TAL Education reports Q3 EPS 2c, consensus 7c TAL TAL Education $61.63 / -1.42 (-2.25%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday TAL TAL Education $61.63 / -1.42 (-2.25%) 03/26/21 Tal Education Group put volume heavy and directionally bearish
Recommendations	Revance price target raised to $37 from $33 at Mizuho » 06:47 04/23/21 04/23 06:47 04/23/21 06:47 RVNC Revance $27.78 / +0.36 (+1.31%) Mizuho analyst Vamil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RVNC Revance $27.78 / +0.36 (+1.31%) 02/22/21 Revance announces 'positive topline data' in ph.2 trial of DaxibotulinumtoxinA 12/22/20 Revance and Ajinomoto announce strategic commercial manufacturing agreement 12/17/20 Revance announces topline results from DaxibotulinumtoxinA trial 12/16/20 Revance to relocate headquarters from Silicon Valley to Nashville RVNC Revance $27.78 / +0.36 (+1.31%) 02/23/21 Mizuho Revance price target raised to $33 from $30 at Mizuho 02/23/21 H.C. Wainwright Revance price target raised to $35 from $33 at H.C. Wainwright 12/29/20 Needham Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List 11/25/20 H.C. Wainwright H.C. Wainwright keeps Buy rating on Revance, says FDA news 'not surprising' RVNC Revance $27.78 / +0.36 (+1.31%) 02/22/21 Revance reports Q4 EPS ($1.24), consensus ($1.24) RVNC Revance $27.78 / +0.36 (+1.31%) 02/22/21 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 04/29/21 Revance 05/05/21 Revance Therapeutics, Inc. 05/20/21 FuboTV
Hot Stocks	Bristol-Myers announces EMA's CHMP recommends approval of Opdivo » 06:47 04/23/21 04/23 06:47 04/23/21 06:47 BMY Bristol-Myers $66.32 / + (+0.00%) Bristol Myers Squibb… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $66.32 / + (+0.00%) 04/16/21 Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer 04/16/21 FDA approves Bristol-Myers' Opdivo for initial treatment of gastric cancer 04/14/21 Bristol-Myers receives EC approval for opdivo-cabometyx combination 04/11/21 Bristol-Myers announces results from CheckMate -816 study BMY Bristol-Myers $66.32 / + (+0.00%) 04/21/21 Citi Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data 04/21/21 Citi Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy 04/13/21 Truist Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility 04/13/21 Truist Bristol-Myers upgraded to Buy from Hold at Truist BMY Bristol-Myers $66.32 / + (+0.00%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $66.32 / + (+0.00%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $66.32 / + (+0.00%) 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11:00 Today Pharmaceuticals 12:00 Today Biotechnology 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $66.32 / + (+0.00%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish

Recommendations	Okta price target raised to $316 from $280 at KeyBanc » 06:46 04/23/21 04/23 06:46 04/23/21 06:46 OKTA Okta $275.10 / +0.26 (+0.09%) KeyBanc analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options OKTA Okta $275.10 / +0.26 (+0.09%) 04/07/21 Fastly and Okta team on in-depth identity protection against security and fraud 03/16/21 Okta appoints Steve Rowland as CRO 03/05/21 Okta CEO: Really excited about the execution of the company 03/03/21 Okta drops 13% to $210.50 after Q1, FY22 profit view miss estimates OKTA Okta $275.10 / +0.26 (+0.09%) 04/22/21 Fly Intel: Top five analyst initiations 04/22/21 Raymond James Okta initiated with an Outperform at Raymond James 04/21/21 Raymond James Okta initiated with an Outperform at Raymond James 04/09/21 Fly Intel: Top five analyst upgrades OKTA Okta $275.10 / +0.26 (+0.09%) 03/03/21 Okta sees FY22 adjusted EPS (49c)-(44c), consensus 1c 03/03/21 Okta sees Q1 adjusted EPS (21c)-(20c), consensus (7c) 03/03/21 Okta reports Q4 adjusted EPS 6c, consensus (1c) 03/03/21 Notable companies reporting after market close OKTA Okta $275.10 / +0.26 (+0.09%) 04/07/21 Okta tells Bloomberg sales seen growing 30% in each of next three years OKTA Okta $275.10 / +0.26 (+0.09%) 03/04/21 Fly Intel: Wall Street's top stories for Thursday 03/04/21 Fly Intel: Wall Street's top stories at midday 03/04/21 Fly Intel: Pre-market Movers 03/03/21 Fly Intel: After-Hours Movers OKTA Okta $275.10 / +0.26 (+0.09%) 12/02/20 Okta options imply 9.8% move in share price post-earnings
Recommendations	Seagate price target raised to $98 from $90 at Morgan Stanley » 06:45 04/23/21 04/23 06:45 04/23/21 06:45 STX Seagate $84.14 / +0.19 (+0.23%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options STX Seagate $84.14 / +0.19 (+0.23%) 04/22/21 Seagate falls 2.5% to $82 per share after Q3 results and guidance 04/22/21 Seagate CEO says Q3 lends further support to outlook for Q4 03/22/21 Seagate names Verizon CIO Arumugavelu to Board 02/24/21 Seagate says on track to deliver 50TB devices by 2026 STX Seagate $84.14 / +0.19 (+0.23%) 06:37 Today Citi Seagate price target raised to $85 from $75 at Citi 04/21/21 Loop Capital Seagate price target raised to $100 from $90 at Loop Capital 04/08/21 Morgan Stanley Seagate price target raised to $90 from $86 at Morgan Stanley 03/22/21 Argus Seagate price target raised to $86 from $75 at Argus STX Seagate $84.14 / +0.19 (+0.23%) 04/22/21 Seagate sees FY21 revenue growth of at least 10%, consensus $10.45B 04/22/21 Seagate sees Q4 EPS $1.45-$1.75, consensus $1.55 04/22/21 Seagate reports Q3 EPS $1.48, consensus $1.32 04/22/21 Notable companies reporting after market close 04 Mar STX Seagate $84.14 / +0.19 (+0.23%) 03/18/21 Seagate probed for allegedly selling hard drives to Huawei, Washington Post says STX Seagate $84.14 / +0.19 (+0.23%) 04/22/21 Fly Intel: After-Hours Movers 03/17/21 McDonald's upgrade, Comcast initiation among today's top calls on Wall Street 02/22/21 Before the Move: Watch Seagate ahead of analyst day 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street STX Seagate $84.14 / +0.19 (+0.23%) 04/22/21 Seagate options imply 7.9% move in share price post-earnings 02/18/21 Early notable gainers among liquid option names on February 18th 01/21/21 Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names
Recommendations	Palo Alto Networks price target raised to $469 from $450 at KeyBanc » 06:45 04/23/21 04/23 06:45 04/23/21 06:45 PANW Palo Alto Networks $352.84 / -4 (-1.12%) KeyBanc analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PANW Palo Alto Networks $352.84 / -4 (-1.12%) 04/05/21 Dish selects Palo Alto Networks to help secure 5G network 03/25/21 Comcast Business, Palo Alto Networks partner for advanced security solutions 03/17/21 Palo Alto Networks names Dipak Goleccha to succeed Luis Visoso as CFO 02/22/21 Palo Alto Networks falls 4.5% to $367 after Q2 results, Q3 guidance PANW Palo Alto Networks $352.84 / -4 (-1.12%) 04/05/21 Credit Suisse Palo Alto Networks assumed with an Outperform at Credit Suisse 03/18/21 Mizuho Palo Alto thesis intact after 'surprising' CFO exit, says Mizuho 03/16/21 Cleveland Research Palo Alto Networks partner checks remain encouraging, says Cleveland Research 03/15/21 Credit Suisse Palo Alto Networks assumed with an Outperform at Credit Suisse PANW Palo Alto Networks $352.84 / -4 (-1.12%) 02/22/21 Palo Alto Networks boosts FY21 adjusted EPS view to $5.80-$5.90, consensus $5.81 02/22/21 Palo Alto Networks sees Q3 adjusted EPS $1.27-$1.29, consensus $1.28 02/22/21 Palo Alto Networks reports Q2 adjusted EPS $1.55, consensus $1.43 02/22/21 Notable companies reporting after market close PANW Palo Alto Networks $352.84 / -4 (-1.12%) 02/16/21 Palo Alto Networks buys Bridgecrew for around $200M, TechCrunch reports 12/17/20 Nuclear weapons agency breached amid massive espionage operation, Politico says PANW Palo Alto Networks $352.84 / -4 (-1.12%) 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 12/31/20 Alphabet, Nordstrom target changes among today's top calls on Wall Street 12/23/20 Telos, Palo Alto seen among potential beneficiaries of Sunburst hack 05/24/21 Global Technology, Media & Communications Virtual Conference PANW Palo Alto Networks $352.84 / -4 (-1.12%) 11/17/20 Unusual call flow in option market yesterday 11/16/20 Post-earning bull in Palo Alto Networks
Upgrade	Sembcorp Industries upgraded to Buy from Sell at Citi » 06:45 04/23/21 04/23 06:45 04/23/21 06:45 SCRPF Sembcorp Industries $1.29 / + (+0.00%) Citi analyst Kwok Wei… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	HCA Healthcare price target raised to $232 from $205 at RBC Capital » 06:45 04/23/21 04/23 06:45 04/23/21 06:45 HCA HCA Healthcare / + RBC Capital analyst Frank… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events HCA HCA Healthcare / + 02/24/21 Brookdale Senior Living to sell 80% stake in BHS to HCA Healthcare for $400M 01/26/21 HCA Healthcare uses Its COVID-19 registry to aid research in area 01/21/21 HCA Healthcare in new JV with A Plus International to expand PPE access 10/26/20 HCA Healthcare sees FY21 EBITDA $10.25B-$10.65B HCA HCA Healthcare / + 04/14/21 Truist HCA Healthcare price target raised to $230 from $200 at Truist 04/13/21 Deutsche Bank HCA Healthcare price target raised to $210 from $180 at Deutsche Bank 04/09/21 Mizuho HCA Healthcare price target raised to $205 from $195 at Mizuho 02/05/21 Mizuho HCA Healthcare price target raised to $195 from $180 at Mizuho HCA HCA Healthcare / + 04/22/21 HCA Healthcare raises FY21 EPS view to $13.30-$14.30 from $12.10-$13.10 04/22/21 HCA Healthcare reports Q1 EPS $4.14, consensus $3.32 04/21/21 Notable companies reporting before tomorrow's open 04/21/21 Notable companies reporting before tomorrow's open HCA HCA Healthcare / + 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says HCA HCA Healthcare / + 04/22/21 Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Pre-market Movers 11/14/20 Week in review: How Trump's policies moved stocks 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 HCA Healthcare, Inc.

Recommendations	Fortinet price target raised to $233 from $195 at KeyBanc » 06:45 04/23/21 04/23 06:45 04/23/21 06:45 FTNT Fortinet $201.08 / -0.81 (-0.40%) KeyBanc analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FTNT Fortinet $201.08 / -0.81 (-0.40%) 03/31/21 PGA TOUR announces Fortinet as title sponsor of Napa tournament 03/22/21 Linksys and Fortinet in pact for security for work from home networks 03/10/21 Fortinet says Fortinet Security Fabric reaches over 400 integrations 03/10/21 Fortinet expands Fortinet Engage Partner Program benefits FTNT Fortinet $201.08 / -0.81 (-0.40%) 04/21/21 Monness Crespi Fortinet price target raised to $225 from $195 at Monness Crespi 04/19/21 BTIG Fortinet price target raised to $240 from $205 at BTIG 04/16/21 Barclays Fortinet price target raised to $210 from $202 at Barclays 03/15/21 Credit Suisse Fortinet assumed with a Neutral at Credit Suisse FTNT Fortinet $201.08 / -0.81 (-0.40%) 02/04/21 Fortinet sees FY21 EPS $3.60-$3.75 consensus $3.63 02/04/21 Fortinet sees Q1 EPS 70-75c, consensus 74c 02/04/21 Fortinet reports Q4 EPS $1.06, consensus 97c 02/04/21 Notable companies reporting after market close FTNT Fortinet $201.08 / -0.81 (-0.40%) 12/17/20 Nuclear weapons agency breached amid massive espionage operation, Politico says FTNT Fortinet $201.08 / -0.81 (-0.40%) 02/04/21 Fly Intel: After-Hours Movers 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 10/29/20 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 04/29/21 Fortinet - FTNT
Recommendations	Snap price target lowered to $80 from $87 at KeyBanc » 06:44 04/23/21 04/23 06:44 04/23/21 06:44 SNAP Snap $57.12 / -1.17 (-2.01%) KeyBanc analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SNAP Snap $57.12 / -1.17 (-2.01%) 04/22/21 Snap Q2 DAU growth rate to be consistent with Q1 04/22/21 Snap says Q1 revenue and DAU growth rates highest in over three years 04/22/21 Snap reports Q1 ARPU $2.74, up 36% from last year 04/22/21 Snap rises roughly 3% to nearly $59 after upbeat Q1 report SNAP Snap $57.12 / -1.17 (-2.01%) 04:53 Today Piper Sandler Piper reiterates $83 target on Snap, says long-term thesis unchanged 04/20/21 MKM Partners Snap positioned for beat and in-line quarter, says MKM Partners 04/19/21 JPMorgan JPMorgan remains positive on Snap into Q1 results 04/16/21 Bernstein Pinterest selloff a 'tactical buying opportunity,' says Bernstein SNAP Snap $57.12 / -1.17 (-2.01%) 04/22/21 Snap sees Q2 revenue $820M-$840M, consensus $826.11M 04/22/21 Snap reports Q1 adjusted EPS 0c, consensus (5c) 04/22/21 Notable companies reporting after market close 02/04/21 Snap sees Q1 revenue $720M-$740M, consensus $704.57M SNAP Snap $57.12 / -1.17 (-2.01%) 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 03/30/21 Snap developing new Spectacles with augmented reality, Information reports 03/05/21 Reddit hires Drew Vollero as CFO ahead of eventual IPO, NY Times reports 02/16/21 ByteDance looks to list Douyin in NY as Biden sets new mood, SCMP reports SNAP Snap $57.12 / -1.17 (-2.01%) 04/22/21 Fly Intel: After-Hours Movers 04/22/21 Fly Intel: What to watch in Snap earnings report 04/21/21 #SocialStocks: House committee looks to rein in Big Tech 04/14/21 #SocialStocks: Facebook removes 16,000 trading groups with fake product reviews SNAP Snap $57.12 / -1.17 (-2.01%) 04/22/21 Snap Inc. options imply 16.0% move in share price post-earnings 04/19/21 Notable open interest changes for April 19th 04/19/21 Snap Inc. call buyer realizes 18% same-day gains 04/12/21 Notable open interest changes for April 12th
Recommendations	Graco price target raised to $89 from $81 at RBC Capital » 06:43 04/23/21 04/23 06:43 04/23/21 06:43 GGG Graco $76.50 / -0.58 (-0.75%) RBC Capital analyst Deane… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GGG Graco $76.50 / -0.58 (-0.75%) 04/21/21 Graco sees improvement in end markets during Q2, cautious on longer term view 02/16/21 Graco announces Mark Sheahan appointed CEO effective June 10 12/04/20 Graco raises quarterly dividend 7.1% to 18.75c per share GGG Graco $76.50 / -0.58 (-0.75%) 03/31/21 Morgan Stanley Graco initiated with an Equal Weight at Morgan Stanley 01/27/21 RBC Capital Graco price target raised to $84 from $78 at RBC Capital 01/26/21 DA Davidson Graco price target raised to $70 from $57 at DA Davidson 01/19/21 Jefferies Graco upgraded to Buy from Hold at Jefferies GGG Graco $76.50 / -0.58 (-0.75%) 04/21/21 Graco reports Q1 EPS 58c, consensus 50c 01/25/21 Graco reports Q4 adjusted EPS 61c, consensus 51c GGG Graco $76.50 / -0.58 (-0.75%) 01/25/21 Fly Intel: After-Hours Movers 14:00 Today Graco Inc
Upgrade	Keyence upgraded to Buy from Neutral at Citi » 06:43 04/23/21 04/23 06:43 04/23/21 06:43 KYCCF Keyence $482.00 / +11 (+2.34%) Citi analyst Graeme… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals KYCCF Keyence $482.00 / +11 (+2.34%) 10/21/20 Goldman Sachs Keyence downgraded to Buy from Conviction Buy at Goldman Sachs KYCCF Keyence $482.00 / +11 (+2.34%) 03/26/21 Danaher, Fortive interested in joint bid for Renishaw, Bloomberg reports
Recommendations	Danaher price target raised to $315 from $280 at KeyBanc » 06:42 04/23/21 04/23 06:42 04/23/21 06:42 DHR Danaher $252.83 / +8.21 (+3.36%) KeyBanc analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events Options DHR Danaher $252.83 / +8.21 (+3.36%) 03/23/21 Beckman Coulter receives Emergency Use Authorization for antibody test 03/11/21 Danaher not seeing decline in Covid testing business 03/02/21 Director of Danaher Mitchell Rales purchases $1.4M in shares 01/13/21 Danaher expects Q4 revenue up approx. 38.5% y-o-y, consensus $6.44B DHR Danaher $252.83 / +8.21 (+3.36%) 06:41 Today RBC Capital Danaher price target raised to $285 from $253 at RBC Capital 06:32 Today Citi Danaher price target raised to $315 from $275 at Citi 04/08/21 Citi Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat 04/07/21 Baird Danaher assumed with an Outperform at Baird DHR Danaher $252.83 / +8.21 (+3.36%) 04/22/21 Danaher sees 2021 non-GAAP core revenue growth in high-teens percent range 04/22/21 Danaher sees Q2 non-GAAP core revenue growth in mid-20 percent range 04/22/21 Danaher reports Q1 adjusted EPS $2.52, consensus $1.75 04/21/21 Notable companies reporting before tomorrow's open 08 May DHR Danaher $252.83 / +8.21 (+3.36%) 03/26/21 Danaher, Fortive interested in joint bid for Renishaw, Bloomberg reports 03/26/21 Danaher said to mull joint bid with Fortive for Renishaw, Bloomberg says 05/05/21 Danaher Corporation DHR Danaher $252.83 / +8.21 (+3.36%) 04/13/21 Early notable gainers among liquid option names on April 13th 01/22/21 Early notable gainers among liquid option names on January 22nd

Recommendations	Genuine Parts price target raised to $129 from $115 at RBC Capital » 06:42 04/23/21 04/23 06:42 04/23/21 06:42 GPC Genuine Parts $119.37 / -1.855 (-1.53%) RBC Capital analyst Scot… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GPC Genuine Parts $119.37 / -1.855 (-1.53%) 04/22/21 Genuine Parts CEO expects to build on 'positive momentum' through 2021 03/01/21 Genuine Parts appoints Napoleon Rutledge as chief accounting officer 02/17/21 Genuine Parts sees FY21 net cash from operating activities $1B-$1.2B 02/17/21 Genuine Parts reports Q4 SSS down 2.8% GPC Genuine Parts $119.37 / -1.855 (-1.53%) 04/21/21 BofA BofA downgrades AutoZone to Underperform, sees good news priced in 02/18/21 RBC Capital Genuine Parts price target raised to $104 from $97 at RBC Capital 12/02/20 Fly Intel: Top five analyst downgrades 12/02/20 BofA Genuine Parts double downgraded to Underperform after doubling at BofA GPC Genuine Parts $119.37 / -1.855 (-1.53%) 04/22/21 Genuine Parts raises FY21 EPS view to $5.85-$6.05 from $5.55-$5.75 04/22/21 Genuine Parts reports Q1 EPS $1.50, consensus $1.14 02/17/21 Genuine Parts sees FY21 diluted EPS $5.55-$5.75, consensus $5.76 02/17/21 Genuine Parts reports Q4 adjusted EPS $1.52, consensus $1.35 GPC Genuine Parts $119.37 / -1.855 (-1.53%) 04/21/21 Netflix, UnitedHealth upgrades among today's top calls on Wall Street 12/10/20 Goldman Sachs says buy Floor & Decor, sell Best Buy 04/29/21 Genuine Parts Company
Upgrade	E.ON upgraded to Buy from Neutral at Citi » 06:41 04/23/21 04/23 06:41 04/23/21 06:41 EONGY E.ON $12.21 / +0.14 (+1.16%) Citi analyst Piotr… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EONGY E.ON $12.21 / +0.14 (+1.16%) 04/19/21 Goldman Sachs E.ON upgraded to Buy from Neutral at Goldman Sachs 04/13/21 Berenberg E.ON price target raised to EUR 11 from EUR 10.50 at Berenberg 03/26/21 Deutsche Bank E.ON price target raised to EUR 11.20 from EUR 11 at Deutsche Bank 02/22/21 Credit Suisse E.ON price target lowered to EUR 10.30 from EUR 10.60 at Credit Suisse
Hot Stocks	Roche announces FDA approval of VENTANA MMR RxDx panel » 06:41 04/23/21 04/23 06:41 04/23/21 06:41 RHHBY Roche $42.52 / -0.67 (-1.55%) , GSK GlaxoSmithKline $37.67 / -0.575 (-1.50%) Roche (RHHBY) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options RHHBY GSK RHHBY Roche $42.52 / -0.67 (-1.55%) 04/22/21 Roche sees completing acquisition of GenMark later today 04/21/21 Replimune Group appoints Sushil Patel as CCO 04/21/21 Roche sees 2021 core EPS growing broadly in line with sales 04/16/21 Genentech announces new Ocrevus analyses at AAN meeting GSK GlaxoSmithKline $37.67 / -0.575 (-1.50%) 04/22/21 GlaxoSmithKline announces FDA approval of JEMPERLI 04/22/21 FDA approves Jemperli for dMMR endometrial cancer 04/22/21 GlaxoSmithKline confirms FDA approval for Jemperli 04/22/21 FDA grants approval to Jemperli for endometrial cancer with specific biomarker RHHBY GSK RHHBY Roche $42.52 / -0.67 (-1.55%) 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation 03/25/21 Wedbush iTeos Therapeutics price target raised to $52 from $46 at Wedbush 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback GSK GlaxoSmithKline $37.67 / -0.575 (-1.50%) 04/20/21 Morgan Stanley GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley 04/20/21 UBS GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS 04/20/21 Citi GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi 03/23/21 Fly Intel: Top five analyst downgrades RHHBY GSK RHHBY Roche $42.52 / -0.67 (-1.55%) 04/21/21 Roche reports Q1 group sales CHF 14.93B vs. CHF 15.14B last year 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using GSK GlaxoSmithKline $37.67 / -0.575 (-1.50%) 02/03/21 GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago RHHBY GSK RHHBY Roche $42.52 / -0.67 (-1.55%) 03/20/21 Still reasons to be hopeful about Lilly, Biogen Alzheimer's drugs, Barron's says 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says GSK GlaxoSmithKline $37.67 / -0.575 (-1.50%) 04/15/21 Activist Elliott builds 'multibillion-pound' stake in GlaxoSmithKline, FT says 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports RHHBY GSK RHHBY Roche $42.52 / -0.67 (-1.55%) 03/23/21 Fly Intel: Wall Street's top stories for Tuesday 03/23/21 Ionis Pharmaceuticals slides as Wall Street digests HD program setback 03/23/21 Fly Intel: Wall Street's top stories at midday 03/23/21 Fly Intel: Pre-market Movers GSK GlaxoSmithKline $37.67 / -0.575 (-1.50%) 03/11/21 Fly Intel: Wall Street's top stories for Thursday 03/11/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 04/28/21 GlaxoSmithKline - GSK GSK GSK GlaxoSmithKline $37.67 / -0.575 (-1.50%) 04/15/21 Unusually active option classes on open April 15th
Recommendations	Goldman Sachs price target raised to $410 from $390 at Citi » 06:41 04/23/21 04/23 06:41 04/23/21 06:41 GS Goldman Sachs $330.66 / -4.77 (-1.42%) Citi analyst Keith… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $330.66 / -4.77 (-1.42%) 04/15/21 Congress to host big bank CEOs for hearings the week of May 24 04/14/21 Goldman Sachs CEO: 'Not focused' on offering crypto wallet right now 04/14/21 Goldman Sachs CEO: 'We have a plan at the moment to build a digital bank' 04/14/21 Goldman Sachs says investment banking backlog ended at record levels in Q1 GS Goldman Sachs $330.66 / -4.77 (-1.42%) 04/21/21 Berenberg Goldman Sachs price target raised to $330 from $270 at Berenberg 04/18/21 BMO Capital OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital 04/16/21 BMO Capital Goldman Sachs price target raised to $432 from $409 at BMO Capital 04/15/21 DA Davidson Goldman Sachs price target raised to $378 from $347 at DA Davidson GS Goldman Sachs $330.66 / -4.77 (-1.42%) 04/14/21 Goldman Sachs reports Q1 EPS $18.60, consensus $10.22 04/13/21 Fly Intel: What to watch in first round of big bank earnings reports 04/13/21 Notable companies reporting before tomorrow's open 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 GS Goldman Sachs $330.66 / -4.77 (-1.42%) 04/16/21 Goldman's corporate communications head to leave bank, NY Times reports 04/10/21 Goldman Sachs had strong pandemic, still room to run, Barron's says 04/09/21 China's Didi Chuxing files confidentially for U.S. IPO, Bloomberg says 04/08/21 Sen. Brown seeks details of banks' ties to Archegos Capital, CNBC reports GS Goldman Sachs $330.66 / -4.77 (-1.42%) 04/14/21 Fly Intel: Wall Street's top stories for Wednesday 04/14/21 Fly Intel: Wall Street's top stories at midday 04/14/21 Fly Intel: Pre-market Movers 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 04/29/21 Goldman Sachs Group Inc. GS Goldman Sachs $330.66 / -4.77 (-1.42%) 04/16/21 Unusually active option classes on open April 16th 04/09/21 Unusually active option classes on open April 9th 03/30/21 Unusually active option classes on open March 30th 03/29/21 Unusually active option classes on open March 29th
Recommendations	Danaher price target raised to $285 from $253 at RBC Capital » 06:41 04/23/21 04/23 06:41 04/23/21 06:41 DHR Danaher $252.83 / +8.21 (+3.36%) RBC Capital analyst Deane… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events Options DHR Danaher $252.83 / +8.21 (+3.36%) 03/23/21 Beckman Coulter receives Emergency Use Authorization for antibody test 03/11/21 Danaher not seeing decline in Covid testing business 03/02/21 Director of Danaher Mitchell Rales purchases $1.4M in shares 01/13/21 Danaher expects Q4 revenue up approx. 38.5% y-o-y, consensus $6.44B DHR Danaher $252.83 / +8.21 (+3.36%) 06:32 Today Citi Danaher price target raised to $315 from $275 at Citi 04/08/21 Citi Citi opens 'positive catalyst watch' on Danaher, sees Q1 beat 04/07/21 Baird Danaher assumed with an Outperform at Baird 03/18/21 KeyBanc Thermo Fisher upgraded to Overweight at KeyBanc after Sartorius guidance DHR Danaher $252.83 / +8.21 (+3.36%) 04/22/21 Danaher sees 2021 non-GAAP core revenue growth in high-teens percent range 04/22/21 Danaher sees Q2 non-GAAP core revenue growth in mid-20 percent range 04/22/21 Danaher reports Q1 adjusted EPS $2.52, consensus $1.75 04/21/21 Notable companies reporting before tomorrow's open 08 May DHR Danaher $252.83 / +8.21 (+3.36%) 03/26/21 Danaher, Fortive interested in joint bid for Renishaw, Bloomberg reports 03/26/21 Danaher said to mull joint bid with Fortive for Renishaw, Bloomberg says 05/05/21 Danaher Corporation DHR Danaher $252.83 / +8.21 (+3.36%) 04/13/21 Early notable gainers among liquid option names on April 13th 01/22/21 Early notable gainers among liquid option names on January 22nd

Events

Earnings calls, analyst events, roadshows and more

SEOAY
Today at 07:00

Stora Enso Oyj - SEOAY Conference Calls
Today at 07:00

Economics & Strategy Industry Meetings
ALV
Today at 08:00

Autoliv - ALV Conference Calls
COTY
Today at 08:00

Coty - COTY Conference Calls
UIS
Today at 08:00

Unisys Corp Firm Sponsored Meetings
MSBI
Today at 08:30

Midland States - MSBI Conference Calls
FFBC
Today at 08:30

First Financial Bancorp - FFBC Conference Calls
HON
Today at 08:30

Honeywell - HON Conference Calls
CBAN
Today at 08:30

Colony Bankcorp - CBAN Conference Calls
AXP
Today at 08:30

American Express - AXP Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares IFBD X IFBD Infobird IPO Managers: WestPark Capital Priced at: $4.00 6.25M Shares
Tues	DV X DV DoubleVerify IPO Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, Truist, William Blair, KeyBanc, Canaccord, JMP Securities, Needham, Loop Capital, Capital One Priced at: $27.00 13.3M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PATH X PATH UiPath IPO Managers: Morgan Stanley & JPMorgan, BofA, Credit Suisse, Barclays, Wells Fargo, SMBC Nikko, BMO Capital, MIZU, KeyBanc, TD Securities, Truist, Cowen, Evercore ISI, Macquarie, Nomura, RBC Capital, Canaccord, DA Davidson, Oppenheimer, Needham Priced at: $56.00 23.89M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SKYT X SKYT SkyWater Technology IPO Managers: Jefferies & Cowen, Piper Sandler Priced at: $14.00 6.96M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRKA X TRKA Troika Media IPO Managers: Kingswood Priced at: $4.15 5.78M Shares FUTU X FUTU Futu Holdings Secondary Managers: BofA & Haitong Priced at: $130.00 9.5M Shares ZLAB X ZLAB Zai Lab Secondary Managers: JPMorgan, Goldman Sachs, Jefferies, Citi, SVB Leerink & Guggenheim Priced at: $150.00 4.78M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NOTV X NOTV Inotiv Spot Secondary Managers: Colliers Priced at: $17.00 2.647M Shares
Wed	KNBE X KNBE KnowBe4 IPO Managers: Morgan Stanley, Goldman Sachs, BofA & KKR Priced at: $16.00 9.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NPCE X NPCE NeuroPace IPO Managers: JPMorgan & Morgan Stanley, Wells Fargo, SVB Leerink Priced at: $17.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZY X ZY Zymergen IPO Managers: JPMorgan & Goldman Sachs, BofA, UBS, LAZA Priced at: $31.00 16.13M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EOLS X EOLS Evolus Spot Secondary Managers: SVB Leerink, Stifel & Cantor Fitzgerald Priced at: $9.50 9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NBSE X NBSE NeuBase Therapeutics Spot Secondary Managers: RBC Capital, Oppenheimer & Chardan, National Securities Priced at: $5.00 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AGTI X AGTI Agiliti IPO Managers: BofA, Goldman Sachs, Morgan Stanley & BMO Capital, Citi, JEFF< UBSW, KeyBanc, Raymond James, MUFG, SMBC Nikko, MISC, SIEB Priced at: $14.00 26.316M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IMPL X IMPL Impel NeuroPharma IPO Managers: Cowen & Guggenheim, Wedbush Priced at: $15.00 5.33M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RAIN X RAIN Rain Therapeutics IPO Managers: Goldman Sachs, Citi, Piper Sandler & Guggenheim Priced at: $17.00 7.353M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SWIM X SWIM Latham Group IPO Managers: Barclays, BofA, Morgan Stanley & Goldman Sachs, Nomura, William Blair, Baird, KeyBanc, Truist Priced at: $19.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TMCI X TMCI Treace Medical IPO Managers: JPMorgan & Morgan Stanley, SVB Leerink, Stifel Priced at: $17.00 11.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDAP X EDAP EDAP TMS Spot Secondary Managers: Piper Sandler Priced at: $6.75 4.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Notable open interest changes for March 2nd

TODAY'S FREE FLY STORIES

Get Full Fly Access